Contact

Our portfolio

ikHerstel

Enhancing post-surgery recovery, ikHerstel offers an e-Health app that provides personalized recovery plans. Their app, based on research from Amsterdam UMC, helps patients recover faster and more effectively. ikHerstel has received significant recognition and funding for their innovative approach. The company is committed to transforming post-operative care through digital health solutions.

  • Institute: Amsterdam UMC
Industry: Digital Health, Rehabilitation
  • Founding year: 2019
Visit website

Want to get in contact about ikHerstel?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Browse all investment managers

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

Phlox Therapeutics
Developing RNA-based therapies for rare genetic heart diseases.
SusPhos
Upcycling phosphate waste into sustainable industrial products.
Arthrogen
Developing local gene therapy for chronic diseases, Arthrogen utilizes viral-mediated gene transfer to treat conditions like rheumatoid arthritis.
ForceSense
Improving surgical skill development with the Lapron Boxtrainer, a laparoscopic training system.
Phlox Therapeutics
Developing RNA-based therapies for rare genetic heart diseases.
SusPhos
Upcycling phosphate waste into sustainable industrial products.
Arthrogen
Developing local gene therapy for chronic diseases, Arthrogen utilizes viral-mediated gene transfer to treat conditions like rheumatoid arthritis.
ForceSense
Improving surgical skill development with the Lapron Boxtrainer, a laparoscopic training system.
Explore full AAV portfolio
Contact